 |
 |
 |
 |
 |
 |
Borison RL, Arvanitis LA, Miller BG.
ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group. J Clin Psychopharmacol.
1996 Apr 1
;
16(2):158-69.
Pubmed Abstract
|
 |
|